If you look at the drug development chart the sales without indication label is the next phase after safety trials. I believe we have sales sooner than some think. I am not getting hopes too high, but it seems clear that the company isn't willing to market a product without first making sure that it is totally safe to administer to skin. Ziv was going to dump this on the market within 30 day's after market ready status but the company realized that is just too much of a liability without testing first.